Alexandra Lupu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alexandra Lupu has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Alexandra‑Mihaela Paşitoniu
1 shared publication- Anca Zanfirescu
Faculty of Pharmacy, “Carol Davila” University of Medicine and Pharmacy, Traian Vuia 6, 020956 Bucharest, Romania
1 shared publication - Cerasela Elena Gîrd
Faculty of Pharmacy, “Carol Davila” University of Medicine and Pharmacy, 020956 Bucharest, Romania
1 shared publication - Corina Andrei
Faculty of Pharmacy, “Carol Davila” University of Medicine and Pharmacy, Traian Vuia 6, 020956 Bucharest, Romania
1 shared publication - Cosmina-Gabriela Duta-Bratu
Faculty of Pharmacy, “Carol Davila” University of Medicine and Pharmacy, Traian Vuia 6, 020956 Bucharest, Romania
1 shared publication - Dumitru Lupuliasa
Faculty of Pharmacy, “Carol Davila” University of Medicine and Pharmacy, 020945 Bucharest, Romania
1 shared publication
Latest Publications
- Open Access
- 28 August 2026
- Published by MDPI AG in Applied Sciences
- Vol. 16 (17) , 8576
Development of Photoprotective Cosmetic Formulations Containing Salix × fragilis Extracts: Phytochemical Characterization, Biological Activity, and In Vitro SPF Evaluation
Salix × fragilis represents a promising botanical source of phenolic compounds with potential applications in photoprotective cosmetics. The present study investigated aqueous (SFw), hydroethanolic (SFhe), and ethanolic (SFe) extracts regarding their phytochemical composition, antioxidant activity, safety profile, photoprotective potential, and applicability in topical formulations. Total phenolic and flavonoid contents were determined spectrophotometrically, while phytochemical profiling was performed by FT-IR and UHPLC–HRMS. Antioxidant activity was evaluated using DPPH, ABTS, and CUPRAC assays. Potential toxicity was preliminarily assessed using Daphnia magna acute and embryo toxicity assays as an alternative screening model for early safety evaluation. Photoprotective activity was estimated by the Mansur spectrophotometric method, and finally, selected extracts were incorporated into cosmetic formulations, followed by physicochemical characterization and in vitro SPF determination. The hydroethanolic extract exhibited the highest phenolic content and antioxidant activity, whereas the ethanolic extract showed the greatest photoprotective capacity, reaching an SPF of 70.0 at 2.0 mg/mL. The investigated extracts exhibited a favorable preliminary safety profile in the Daphnia magna model, with only the hydroethanolic extract producing a measurable 48 h LC50 (576.5 μg/mL), whereas no evident embryotoxic or teratogenic effects were observed, supporting their further investigation using complementary safety models. Selected extracts were successfully incorporated into cosmetic formulations, which were subsequently physicochemically characterized. Incorporation of the ethanolic extract increased the SPF of the UV filter-containing formulation from 25.82 to 30.01 (approximately 16%).
- 28 August 2026
- Published by MDPI AG in Applied Sciences
- Vol. 16 (17) , 8576
Open AccessDevelopment of Photoprotective Cosmetic Formulations Containing Salix × fragilis Extracts: Phytochemical Characterization, Biological Activity, and In Vitro SPF Evaluation
Salix × fragilis represents a promising botanical source of phenolic compounds with potential applications in photoprotective cosmetics. The present study investigated aqueous (SFw), hydroethanolic (SFhe), and ethanolic (SFe) extracts regarding their phytochemical composition, antioxidant activity, safety profile, photoprotective potential, and applicability in topical formulations. Total phenolic and flavonoid contents were determined spectrophotometrically, while phytochemical profiling was performed by FT-IR and UHPLC–HRMS. Antioxidant activity was evaluated using DPPH, ABTS, and CUPRAC assays. Potential toxicity was preliminarily assessed using Daphnia magna acute and embryo toxicity assays as an alternative screening model for early safety evaluation. Photoprotective activity was estimated by the Mansur spectrophotometric method, and finally, selected extracts were incorporated into cosmetic formulations, followed by physicochemical characterization and in vitro SPF determination. The hydroethanolic extract exhibited the highest phenolic content and antioxidant activity, whereas the ethanolic extract showed the greatest photoprotective capacity, reaching an SPF of 70.0 at 2.0 mg/mL. The investigated extracts exhibited a favorable preliminary safety profile in the Daphnia magna model, with only the hydroethanolic extract producing a measurable 48 h LC50 (576.5 μg/mL), whereas no evident embryotoxic or teratogenic effects were observed, supporting their further investigation using complementary safety models. Selected extracts were successfully incorporated into cosmetic formulations, which were subsequently physicochemically characterized. Incorporation of the ethanolic extract increased the SPF of the UV filter-containing formulation from 25.82 to 30.01 (approximately 16%).
- Open Access
- 1 January 2024
- Published by MedicHub Media in Farmacist.ro
- Vol. 2 (217) , 22
The pharmacist’s guide to using SPF products throughout the year
The use of sun protection products has seen a significant evolution in terms of usage frequency in recent years. These products have transitioned from only offering protection against erythema – i.e., sunburns caused by UV rays – to broad-spectrum UV protection products. They not only prevent erythema but also offer multiple benefits in the fight against photoaging of the skin, depigmentation, protects the integrity of cellular DNA, and reduce the risk of photocarcinogenesis. A synthesis of research in the field of UV protection highlights the essential aspects regarding sunscreen products, including the advantages and disadvantages of the most commonly used UV filters. This article underscores the crucial aspects that healthcare professionals need to consider in order to provide informed guidance to patients regarding sun protection products.
- 1 January 2024
- Published by MedicHub Media in Farmacist.ro
- Vol. 2 (217) , 22
Open AccessThe pharmacist’s guide to using SPF products throughout the year
The use of sun protection products has seen a significant evolution in terms of usage frequency in recent years. These products have transitioned from only offering protection against erythema – i.e., sunburns caused by UV rays – to broad-spectrum UV protection products. They not only prevent erythema but also offer multiple benefits in the fight against photoaging of the skin, depigmentation, protects the integrity of cellular DNA, and reduce the risk of photocarcinogenesis. A synthesis of research in the field of UV protection highlights the essential aspects regarding sunscreen products, including the advantages and disadvantages of the most commonly used UV filters. This article underscores the crucial aspects that healthcare professionals need to consider in order to provide informed guidance to patients regarding sun protection products.